Related Experiment Videos
Cell adhesion molecules in cardiovascular disease: a clinical perspective
1Department of Cardiology, Royal Infirmary, Edinburgh, UK.
Heart (British Cardiac Society)
|July 11, 1998
Summary
Cell adhesion molecules are crucial in cardiovascular diseases like thrombosis and inflammation. Targeting these molecules, such as integrins, offers promising future treatments for heart conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Immunology
Background:
- Cell adhesion molecules (CAMs) are increasingly recognized for their significant role in cardiovascular pathology.
- These molecules mediate key processes in cardiac disease development, including thrombosis, inflammation, and cell proliferation.
Purpose of the Study:
- To review the critical involvement of cell adhesion molecules in cardiovascular diseases.
- To highlight the therapeutic potential of targeting CAMs for treating cardiac conditions.
Main Methods:
- Literature review of studies investigating the role of CAMs in cardiovascular pathology.
- Analysis of existing clinical applications and future prospects of CAM-targeted therapies.
Main Results:
- CAMs are integral to processes such as thrombosis, leukocyte infiltration, smooth muscle proliferation, and cell migration in the heart.
- Anti-integrin therapies are established treatments for thrombotic complications.
Conclusions:
- Cell adhesion molecules are pivotal players in the pathogenesis of cardiovascular diseases.
- Targeting various CAMs represents a promising avenue for future clinical interventions in cardiology.